A new gene-editing therapy for sickle cell disease is using CRISPR to correct the mutation behind the disease, developers have announced.
Patients are being enrolled for a US-based trial, which will seek to correct the mutation within patients鈥� ow...
6 months ago
This month, there are some BSH news items to share with you.
Firstly, at the end of the year, we say goodbye to John Barrett after six years as Editor-in-Chief of the British Journal of 91黄网 (BJHaem). We thank John for modernising the journ...
6 months ago
